Tag: Beyfortus
Dr Reddy’s & Sanofi Healthcare expand partnership to launch Beyfortus, a...
Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season